Privia Health Group, Inc. (NASDAQ:PRVA) Given Consensus Recommendation of “Buy” by Analysts

Privia Health Group, Inc. (NASDAQ:PRVA) has received a consensus recommendation of “Buy” from the seventeen research firms that are covering the firm, MarketBeat reports. Two analysts have rated the stock with a hold recommendation, thirteen have issued a buy recommendation and two have assigned a strong buy recommendation to the company. The average 1-year price target among brokers that have issued a report on the stock in the last year is $24.88.

Several equities research analysts have recently commented on PRVA shares. KeyCorp started coverage on shares of Privia Health Group in a research note on Friday, October 11th. They set an “overweight” rating and a $23.00 price objective for the company. Barclays lifted their price target on Privia Health Group from $19.00 to $21.00 and gave the stock an “equal weight” rating in a research report on Friday, November 8th. Stephens reissued an “overweight” rating and issued a $26.00 price objective on shares of Privia Health Group in a report on Thursday, January 2nd. Truist Financial lifted their target price on Privia Health Group from $24.00 to $27.00 and gave the stock a “buy” rating in a report on Friday, November 8th. Finally, JPMorgan Chase & Co. upped their target price on Privia Health Group from $27.00 to $28.00 and gave the company an “overweight” rating in a research report on Friday, November 29th.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. Sequoia Financial Advisors LLC boosted its stake in shares of Privia Health Group by 2.3% during the 3rd quarter. Sequoia Financial Advisors LLC now owns 26,246 shares of the company’s stock worth $478,000 after acquiring an additional 583 shares in the last quarter. Benjamin F. Edwards & Company Inc. boosted its position in Privia Health Group by 8.5% during the second quarter. Benjamin F. Edwards & Company Inc. now owns 7,695 shares of the company’s stock worth $134,000 after purchasing an additional 605 shares in the last quarter. Arizona State Retirement System grew its holdings in Privia Health Group by 2.4% in the second quarter. Arizona State Retirement System now owns 26,574 shares of the company’s stock valued at $462,000 after purchasing an additional 617 shares during the period. GAMMA Investing LLC increased its position in shares of Privia Health Group by 98.7% in the third quarter. GAMMA Investing LLC now owns 1,701 shares of the company’s stock valued at $31,000 after buying an additional 845 shares in the last quarter. Finally, KBC Group NV raised its stake in shares of Privia Health Group by 34.6% during the 3rd quarter. KBC Group NV now owns 3,385 shares of the company’s stock worth $62,000 after buying an additional 871 shares during the period. Hedge funds and other institutional investors own 94.48% of the company’s stock.

Privia Health Group Stock Up 0.2 %

PRVA stock opened at $20.30 on Wednesday. The stock has a market capitalization of $2.44 billion, a PE ratio of 203.02, a price-to-earnings-growth ratio of 5.45 and a beta of 0.85. Privia Health Group has a 52 week low of $15.92 and a 52 week high of $23.78. The firm has a 50 day moving average of $20.80 and a 200 day moving average of $19.38.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.